Entering text into the input field will update the search result below

NuSkin in the news again

Apr. 07, 2011 7:19 AM ETNUS
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Nu Skin Enterprises (NUS), a company which develops and distributes anti-aging personal care products and nutritional supplements worldwide, gained over 6% in trade due to re-iterated FY 11 guidance and a better than expected outlook for Q1F11.

The company announced that the Q1F11 revenues will be up 9% (v/s previously guided +4-7%) with currencies growth at 5% (v/s 2-3% guided earlier). The EPS for Q1F11 was raised to $0.52-0.54 from $0.50-0.53 guided earlier. The management also clarified that the negative impact of Japan (~30% of revenues) would be more than offset by the growth in other Asia Pacific markets.

The management expects the sales in Japan to come down by 7%, whereas the China and South Asian markets are expected to clock ~38% growth. The management reiterated EPS range of $2.25-2.35 for the full FY11. The stock is trading at a P/E of ~13x FY11e which is lower than that of its peers. The stock is a good buy at these levels given the positive growth outlook and cash flow situation.

Yes I'm long NUS.

Live With Intention,

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.